Form 4: Carlyle Group Sells Shares of QuidelOrtho Corp (QDEL) Under 10b5-1 Trading Plan

Carlyle Group executed multiple sales of QuidelOrtho Corp (QDEL) common stock on July 18 and 19, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Carlyle Group, a significant shareholder of QuidelOrtho Corp (QDEL), has reported the sale of shares of common stock.
• The sales occurred on July 18 and 19, 2024.
• The transactions were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• On July 18, 2024, Carlyle sold 53,224 shares at a weighted average price of $33.4592, 32,989 shares at a weighted average price of $34.7526, and 15,657 shares at a weighted average price of $35.0852.
• On July 19, 2024, Carlyle sold 1,500 shares at $32.93, 21,182 shares at a weighted average price of $33.5406, and 42,954 shares at a weighted average price of $34.4528.
• Following these transactions, Carlyle Group's indirect beneficial ownership stands at 10,562,558 shares.
• The shares are held of record by Carlyle Partners VI Cayman Holdings, L.P.
• Carlyle Group Inc. disclaims beneficial ownership of these securities.

Sentiment

Score: 5

Explanation: The document itself is neutral as it simply reports transactions. However, the fact that a major shareholder is selling shares could be interpreted slightly negatively, hence a score of 5.

Negatives

• Carlyle Group, a 10% owner, is reducing its stake in QuidelOrtho, which could be perceived negatively by the market.

Risks

• Continued sales by Carlyle Group could put downward pressure on QDEL's stock price.
• The market may react negatively to the reduction in Carlyle's stake, interpreting it as a lack of confidence in the company's future prospects.

Future Outlook

The document does not contain any specific forward-looking statements regarding QuidelOrtho's future performance.

Industry Context

Form 4 filings are routine disclosures for significant shareholders and provide transparency into their trading activities. The impact on QuidelOrtho depends on the size and frequency of such transactions and the overall market sentiment towards the healthcare sector and diagnostic companies.

Stakeholder Impact

• Shareholders may react to the news of Carlyle Group selling shares.
• The stock price could be affected by these transactions.

Key Dates